Fortrea Holdings Inc. (FTRE)
(Delayed Data from NSDQ)
$24.88 USD
+0.03 (0.12%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $24.86 -0.02 (-0.08%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
FTRE 24.88 +0.03(0.12%)
Will FTRE be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for FTRE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FTRE
Company News for Mar 12, 2024
Cognizant (CTSH), Microsoft Team Up to Streamline Healthcare
FTRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cognizant (CTSH) Expands Gen-AI Footprint With Flowsource
Cognizant (CTSH) Boosts Innovation With Microsoft AI Assistant
Cognizant (CTSH) Expands Healthcare Footprint With Fortrea Deal
Other News for FTRE
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Fortrea Holdings Divests Enabling Services for $340M
Fortrea completes divestiture of Endpoint Clinical, Fortrea Patient Access
Fortrea to Present at the Jefferies Global Healthcare Conference
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research